» Authors » Rosaria Di Mauro

Rosaria Di Mauro

Explore the profile of Rosaria Di Mauro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 140
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bellanca C, Augello E, Mariottini A, Bonaventura G, La Cognata V, Di Benedetto G, et al.
Curr Neuropharmacol . 2024 Jan; 22(8):1286-1326. PMID: 38275058
Multiple sclerosis (MS) is the most prevalent chronic autoimmune inflammatory- demyelinating disorder of the central nervous system (CNS). It usually begins in young adulthood, mainly between the second and fourth...
2.
Bellanca C, Augello E, Cantone A, Di Mauro R, Attaguile G, Di Giovanni V, et al.
Pharmaceuticals (Basel) . 2023 Nov; 16(11). PMID: 38004408
The European Medicine Agency (EMA) has defined Adverse Drug Reactions (ADRs) as "a noxious and unintended response to a medicine", not including poisoning, accidental, or intentional overdoses. The ADR occurrence...
3.
Di Benedetto G, Burgaletto C, Serapide M, Caltabiano R, Munafo A, Bellanca C, et al.
Int J Mol Sci . 2022 Oct; 23(19). PMID: 36232931
TRAIL, a member of TNF superfamily, is a potent inducer of neuronal death. Neurotoxic effects of TRAIL appear mediated by its death receptor TRAIL-R2/DR5. To assess the role of TRAIL/TRAIL-R2...
4.
Marino A, Munafo A, Zagami A, Ceccarelli M, Campanella E, Cosentino F, et al.
IDCases . 2022 Mar; 28:e01462. PMID: 35265458
Enterococcus faecalis infective endocarditis (EFIE) continues to be a very serious disease, showing considerable morbidity and mortality rates which are influenced by the spread of multi-drug resistant strains occurred in...
5.
Marino A, Munafo A, Zagami A, Ceccarelli M, Di Mauro R, Cantarella G, et al.
J Clin Med . 2021 Oct; 10(19). PMID: 34640612
infective endocarditis (EFIE) continues to represent a potentially fatal infectious disease characterized by elevated morbidity and mortality. Despite advances in antimicrobial therapy, changing demographics and the reduced availability of useful...
6.
Bonaventura G, Munafo A, Bellanca C, La Cognata V, Iemmolo R, Attaguile G, et al.
Cells . 2021 Aug; 10(8). PMID: 34440761
Neurodegenerative diseases are characterized by the progressive loss of structure and/or function of both neurons and glial cells, leading to different degrees of pathology and loss of cognition. The hypothesis...
7.
Munafo A, Frara S, Perico N, Di Mauro R, Cortinovis M, Burgaletto C, et al.
Rev Endocr Metab Disord . 2021 May; 22(4):1013-1025. PMID: 33945051
Obesity is a major public health problem worldwide. Only relatively few treatment options are, at present, available for the management of obese patients. Furthermore, treatment of obesity is affected by...
8.
Munafo A, Burgaletto C, Di Benedetto G, Di Mauro M, Di Mauro R, Bernardini R, et al.
Front Neurosci . 2020 Dec; 14:614643. PMID: 33343293
Alzheimer's disease (AD) is the most common age-related neurodegenerative disorder characterized by cognitive decline and by the presence of amyloid β plaques and neurofibrillary tangles in the brain. Despite recent...
9.
Ronsisvalle S, Panarello F, Di Mauro R, Bernardini R, Volti G, Cantarella G
Curr Pharm Des . 2020 Dec; 27(10):1323-1329. PMID: 33302855
Background: The evolution of the pandemic has burdened the national healthcare systems worldwide and at present, there is no preferred antiviral treatment for COVID-19. Recently, the SARS-Cov-2 protease structure was...
10.
Burgaletto C, Munafo A, Di Benedetto G, De Francisci C, Caraci F, Di Mauro R, et al.
J Neuroinflammation . 2020 Oct; 17(1):298. PMID: 33050925
Alzheimer's disease (AD) is the most common form of dementia, characterized by progressive degeneration and loss of neurons in specific regions of the central nervous system. Chronic activation of the...